Michele Celestino
Overview
Explore the profile of Michele Celestino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dieci M, Azzarello G, Zagonel V, Bassan F, Gori S, Aprile G, et al.
Eur J Cancer
. 2022 Apr;
167:81-91.
PMID: 35398759
Introduction: We analyzed a cohort of patients with cancer and Sars-Cov-2 infection from the Veneto Oncology Network registry across two pandemic time periods. Materials And Methods: 761 patients with cancer...
2.
Vogiatzis S, Celestino M, Trevisan M, Magro G, Del Vecchio C, Erdengiz D, et al.
Cells
. 2021 Nov;
10(11).
PMID: 34831478
One of the main pathological features of Parkinson's disease (PD) is a diffuse accumulation of alpha-synuclein (aS) aggregates in neurons. The NEDD4 E3 Ub ligase promotes aS degradation by the...
3.
Guarneri V, Bassan F, Zagonel V, Milella M, Zaninelli M, Cattelan A, et al.
Eur J Cancer
. 2021 Mar;
147:120-127.
PMID: 33647547
Introduction: Coronavirus disease 2019 (COVID-19) pandemic started in Italy with clusters identified in Northern Italy. The Veneto Oncology Network (Rete Oncologica Veneta) licenced dedicated guidelines to ensure proper care minimising...
4.
Celestino M, Balmaceda Valdez V, Brun P, Castagliuolo I, Mucignat-Caretta C
Sci Rep
. 2021 Jan;
11(1):481.
PMID: 33436880
Monosodium Glutamate (MSG) is used as flavour enhancer, with potential beneficial effects due to its nutritional value. Given the decline in kidney functions during aging, we investigated the impact of...
5.
Del Vecchio C, Celestino M, Celegato M, Palu G, Parolin C, Bouamr F, et al.
J Virol
. 2020 Mar;
94(11).
PMID: 32213612
The structural protein Gag is the only viral component required for retroviral budding from infected cells. Each of the three conserved domains-the matrix (MA), capsid (CA), and nucleocapsid (NC) domains-drives...
6.
Salata C, Calistri A, Alvisi G, Celestino M, Parolin C, Palu G
Viruses
. 2019 Mar;
11(3).
PMID: 30893774
Ebola Virus Disease (EVD) is one of the most lethal transmissible infections, characterized by a high fatality rate, and caused by a member of the family. The recent large outbreak...
7.
Salata C, Monteil V, Karlberg H, Celestino M, Devignot S, Leijon M, et al.
Emerg Microbes Infect
. 2018 Nov;
7(1):190.
PMID: 30482897
No abstract available.
8.
Caduco M, Comin A, Toffoletto M, Munegato D, Sartori E, Celestino M, et al.
J Virol
. 2012 Oct;
87(1):692-6.
PMID: 23077308
Ubiquitination/deubiquitination of key factors represent crucial steps in the biogenesis of multivesicular body (MVB) and sorting of transmembrane proteins. We and others previously demonstrated that MVB is involved in herpes...
9.
Celestino M, Calistri A, Del Vecchio C, Salata C, Chiuppesi F, Pistello M, et al.
J Virol
. 2012 Apr;
86(12):6688-700.
PMID: 22514338
Tetherin (BST2) is the host cell factor that blocks the particle release of some enveloped viruses. Two putative feline tetherin proteins differing at the level of the N-terminal coding region...
10.
Calistri A, Del Vecchio C, Salata C, Celestino M, Celegato M, Gottlinger H, et al.
J Cell Physiol
. 2008 Sep;
218(1):175-82.
PMID: 18792916
RNA-enveloped viruses bud from infected cells by exploiting the multivesicular body (MVB) pathway. In this context, ubiquitination of structural viral proteins and their direct interaction with cellular factors involved in...